CA2251344A1 - Methodes et composition de depistage ou de modulation d'un antigene associe aux tumeurs - Google Patents

Methodes et composition de depistage ou de modulation d'un antigene associe aux tumeurs Download PDF

Info

Publication number
CA2251344A1
CA2251344A1 CA 2251344 CA2251344A CA2251344A1 CA 2251344 A1 CA2251344 A1 CA 2251344A1 CA 2251344 CA2251344 CA 2251344 CA 2251344 A CA2251344 A CA 2251344A CA 2251344 A1 CA2251344 A1 CA 2251344A1
Authority
CA
Canada
Prior art keywords
antigen
seq
nucleic acid
ser
glu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2251344
Other languages
English (en)
Inventor
G. Michael Hass
Robert J. Kinders
David L. Enfield
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Bard Diagnostic Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bard Diagnostic Sciences Inc filed Critical Bard Diagnostic Sciences Inc
Publication of CA2251344A1 publication Critical patent/CA2251344A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Méthodes de dépistage ou de traitement du cancer. Les méthodes de dépistage se fondent sur la détection d'un antigène, ou d'une molécule d'acide nucléique codant l'antigène, cet antigène étant selon l'invention lié à la présence d'un cancer. Les modes de réalisation préférés sont notament la détection de l'antigène à partir de ses propriétés immunologiques, de ses propriétés physiques, de ses propriétés enzymatiques et de l'ensemble de celle-ci, ou la détection d'une molécule d'acide nucléique codant l'antigène à partir de l'amplification de l'acide nucléique.
CA 2251344 1996-04-09 1997-04-09 Methodes et composition de depistage ou de modulation d'un antigene associe aux tumeurs Abandoned CA2251344A1 (fr)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US1508396P 1996-04-09 1996-04-09
US63004896A 1996-04-09 1996-04-09
US60/015,083 1996-04-09
US08/630,048 1996-04-09
US81248197A 1997-03-06 1997-03-06
US3861497P 1997-03-06 1997-03-06
US08/812,481 1997-03-06
US60/038,614 1997-03-06

Publications (1)

Publication Number Publication Date
CA2251344A1 true CA2251344A1 (fr) 1997-10-16

Family

ID=27486448

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2251344 Abandoned CA2251344A1 (fr) 1996-04-09 1997-04-09 Methodes et composition de depistage ou de modulation d'un antigene associe aux tumeurs

Country Status (4)

Country Link
EP (1) EP0917589A1 (fr)
AU (1) AU718842B2 (fr)
CA (1) CA2251344A1 (fr)
WO (1) WO1997038136A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000015259A1 (fr) * 1998-09-10 2000-03-23 The University Of Virginia Patent Foundation Anticorps anti-c3b(i) pouvant diffuser des agents diagnostiques ou therapeutiques dans des cellules cancereuses

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6572856B1 (en) 1998-09-10 2003-06-03 The University Of Virginia Patent Foundation Methods for the prevention and treatment of cancer using anti-C3b(i) antibodies
GB0618217D0 (en) * 2006-09-15 2006-10-25 Ares Trading Sa FHR-4A splicing variants
CN108828220B (zh) * 2018-03-29 2021-07-09 杭州泰熙生物技术有限公司 一种检测保健品中苯二氮卓类物质的检测卡及其制备方法
CN111763243B (zh) * 2020-05-22 2021-01-29 浙江海洋大学 小公鱼免疫活性肽及其制备方法和用途

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000015259A1 (fr) * 1998-09-10 2000-03-23 The University Of Virginia Patent Foundation Anticorps anti-c3b(i) pouvant diffuser des agents diagnostiques ou therapeutiques dans des cellules cancereuses

Also Published As

Publication number Publication date
EP0917589A1 (fr) 1999-05-26
WO1997038136A1 (fr) 1997-10-16
AU718842B2 (en) 2000-04-20
AU2660897A (en) 1997-10-29

Similar Documents

Publication Publication Date Title
JP3989528B2 (ja) Ｄｎａ配列及びエンコードされた乳房に特異的な乳癌たんぱく質
AU735338B2 (en) Mammaglobin, a secreted mammary-specific breast cancer protein
EP1876241A2 (fr) Compositions et procédés pour le traitement et le diagnostic du cancer du sein
KR19990087802A (ko) 전립선암의 면역치료 및 면역진단을 위한 화합물 및 방법
AU678487B2 (en) Compositions and diagnostic methods using monoclonal antibodies against CD44v6
EP2143731A1 (fr) Composés pour l'immunothérapie du cancer de la prostate et procédés pour leur utilisation
US6017703A (en) Methods and compositions for screening for or modulating a tumor associated antigen
US5879898A (en) Antibodies specific for peptide corresponding to CD44 exon 6, and use of these antibodies for diagnosis of tumors
EP1127893A2 (fr) Compositions thérapeutiques et diagnostiques du carcinome mammaire et méthodes afférentes
WO1997025431A1 (fr) Compositions et procedes de traitement et de diagnostic du cancer
JPH08506801A (ja) Ｃｄ４４エキソン６に対応するペプチド、そのペプチドに特異的な抗体、および、腫瘍診断にそれらの抗体を使用する方法
JP2002525098A5 (fr)
WO2000018783A9 (fr) La mammaglobine, une proteine secretee specifique aux tumeurs mammaires dans le cancer du sein
WO2002077243A1 (fr) Diagnostic de cancer ou de tumeur benigne par utilisation du produit d'expression aberrante du gene klk4
AU718842B2 (en) Methods and compositions for screening for or modulating a tumor associated antigen
US5942402A (en) Method of detecting and treating cancer
EP0972200A1 (fr) Criblage et traitement au moyen d'un regulateur du complement ou de proteines receptrices du complement
WO1998039659A9 (fr) Criblage et traitement au moyen d'un regulateur du complement ou de proteines receptrices du complement
EP2078728A1 (fr) Nouvelle isoforme du versican et utilisation pour le diagnostic et le traitement
EP0471825A1 (fr) METHODES DE DIAGNOSTIQUE UTILISANT DES GENES PTPase ET LEURS UTILISATIONS
US7008772B1 (en) Compounds for immunodiagnosis of prostate cancer and methods for their use
AU767962B2 (en) Mammaglobin, a secreted mammary-specific breast cancer protein
MXPA00002810A (en) Mammaglobin, a secreted mammary-specific breast cancer protein

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead